ARXX THERAPEUTICS AS

Signals

2 flags

• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−66,8 mill kr).
• ◎ Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

ARXX THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 815295242. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2015. Registered share capital is NOK 5.5m, divided into 26043511 shares. The company's stated purpose is: “Utvikle, markedsføre og selge legemidler.”. The most recent filed accounts, for the 2024 financial year, show NOK 5.0m in revenue and NOK −66.8m in operating profit.

Key figures · 2024

Revenue

NOK 5.0m

Operating profit

NOK −66.8m

Equity

NOK 13.5m

Est. value

NOK 11.8m

Financial health · 2024

Liquidity

1.18

Satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

15.9%

Satisfactory

Equity as a share of total capital

Who owns ARXX THERAPEUTICS AS?

CALLUNA PHARMA AS

100.0%

ARXX THERAPEUTICS AS

NOK 5.0m rev. · NOK −66.8m profit

ARXX THERAPEUTICS AS has 1 registered shareholder:

• CALLUNA PHARMA AS 100.0%

All shareholders and roles →

Frequently asked questions about ARXX THERAPEUTICS AS

Who owns ARXX THERAPEUTICS AS?

CALLUNA PHARMA AS is the largest registered owner, with 100.0%.

What is the revenue of ARXX THERAPEUTICS AS?

ARXX THERAPEUTICS AS had revenue of NOK 5.0m in 2024.

Where is ARXX THERAPEUTICS AS based?

ARXX THERAPEUTICS AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.